News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Elutia
NEWS
JOBS
NEWS
FDA
Excessive Impurities Cause Recall of Pfizer’s Anti-Smoking Drug
Pfizer has voluntarily recalled two lots of Chantix 0.5 mg tablets, two lots of Chantix 1 mg tablets, and eight lots of a Chantix kit consisting of 0.5mg/1 mg tablets.
July 20, 2021
·
2 min read
·
Brandon May
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
·
1 min read
IN THE PRESS
Business
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices
September 18, 2024
·
6 min read
News
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
September 5, 2024
·
6 min read
Press Releases
Elutia to Participate in Upcoming Investor Conferences
September 4, 2024
·
1 min read
Press Releases
Elutia Announces Second Quarter 2024 Results
August 8, 2024
·
14 min read
Press Releases
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
August 1, 2024
·
2 min read
Press Releases
Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
July 31, 2024
·
1 min read
BioCapital
Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
June 17, 2024
·
7 min read
Business
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
May 2, 2024
·
1 min read
Business
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
March 7, 2024
·
15 min read
Business
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
February 22, 2024
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details